Sepsis is not an infection. It is your immune system's catastrophic overreaction to one — a dysregulated cascade that destroys organs, collapses circulation, and kills 11 million people every year. Every hour of delay costs lives.
Sepsis is the leading cause of death in hospitals worldwide. It kills more people than cancer, heart attacks, and stroke combined. Yet it remains one of the most difficult conditions to detect early because its initial presentation — fever, elevated heart rate, altered mental status — mimics dozens of other conditions. By the time a blood culture confirms infection and organ dysfunction scores trigger a sepsis alert, the cascade is already underway and the golden hour has already passed.
Sentinel Sepsis does not wait for the cascade. It detects the earliest immunological, hemodynamic, and metabolic signatures of sepsis onset — 4 to 6 hours before traditional clinical criteria are met — and immediately activates a coordinated response: source identification, empiric antimicrobial therapy, hemodynamic resuscitation, organ protection, and continuous treatment optimization. One platform. Nine engines. The full sepsis response — from first signal to sustained recovery.
Sepsis is not a binary event — it is a progressive cascade. Each stage narrows the treatment window and escalates mortality. Sentinel Sepsis monitors every stage simultaneously.
Machine learning has identified four distinct sepsis phenotypes — each with different inflammatory profiles, organ dysfunction patterns, and mortality rates. Sentinel Sepsis classifies each patient in real time, enabling phenotype-specific treatment strategies.
Lowest organ dysfunction severity. Minimal inflammation. Typically younger patients with fewer comorbidities. Best prognosis with standard sepsis bundles.
Older patients with chronic kidney disease, diabetes, and vascular disease. Moderate organ dysfunction but prolonged recovery trajectories. Requires renal-protective resuscitation and careful fluid management.
Marked inflammatory response with high fevers, elevated CRP, procalcitonin, and ferritin. Respiratory failure develops rapidly. Responds to early, aggressive source control and may benefit from immunomodulatory therapy.
The most severe phenotype. Characterized by profound coagulopathy (DIC), hepatic dysfunction, lactic acidosis, and vasoplegic shock. Requires maximum ICU resources: multiple vasopressors, continuous renal replacement, mechanical ventilation, and hematology co-management for DIC.
Each engine addresses a distinct domain of sepsis management — from prediction through sustained recovery.
Sentinel Sepsis continuously monitors every hospitalized patient across 200+ clinical variables — vital sign trajectories, laboratory trends, medication responses, nursing documentation, and hemodynamic waveforms — to detect the earliest immunological and metabolic signatures of sepsis onset. The system flags sepsis risk 4-6 hours before traditional screening tools (qSOFA, NEWS2, SIRS) trigger, during the critical window when early antibiotics and fluid resuscitation can prevent organ failure entirely.
The model was trained on 18 million de-identified encounters, achieves an AUC of 0.97 for sepsis detection, and maintains an 89% alert adoption rate across deployed sites — because it has been engineered from the ground up to minimize false positives. The system achieves an 8% false-positive rate versus the 90%+ false-positive rate of traditional SIRS-based screening.
Source control is the foundation of sepsis treatment. You cannot treat sepsis effectively without knowing where the infection lives. Sentinel Sepsis analyzes the clinical picture — imaging findings, culture results, surgical history, device presence (central lines, urinary catheters, surgical drains), and symptom patterns — to identify the most likely infection source and recommend targeted diagnostic workup and source control interventions. The system identifies pulmonary, urinary, abdominal, central line, skin/soft tissue, and CNS sources with 88% accuracy within the first 2.4 hours of sepsis recognition.
Every hour of delay in appropriate antibiotic therapy increases sepsis mortality by 7.6%. But inappropriate broad-spectrum antibiotics fuel antimicrobial resistance — which itself kills 1.27 million people annually. Sentinel Sepsis resolves this tension by predicting the most likely pathogen based on infection source, patient history, local antibiogram, and prior antibiotic exposure — then recommending the narrowest effective empiric coverage. When cultures return (typically 48-72 hours later), the system automatically recommends de-escalation to targeted therapy and flags opportunities to switch from IV to oral formulations.
Sepsis resuscitation is a razor's edge. Too little fluid and the organs starve. Too much fluid and the lungs drown. The Surviving Sepsis Campaign recommends 30 mL/kg crystalloid within 3 hours — but this one-size-fits-all approach does not account for the patient's cardiac function, pulmonary reserve, or volume status. Sentinel Sepsis provides real-time hemodynamic guidance: monitoring MAP, lactate clearance, urine output, ScvO2, pulse pressure variation, and echocardiographic parameters to recommend personalized fluid volumes, vasopressor titration, and the optimal moment to transition from resuscitation to maintenance.
Sepsis destroys organs in a specific sequence determined by the patient's physiology, comorbidities, and the infection source. Sentinel Sepsis continuously calculates SOFA scores across six organ systems (respiratory, coagulation, liver, cardiovascular, CNS, renal) and projects the trajectory of each — predicting which organs are most likely to fail next and recommending preemptive protective measures (renal-dose adjustment, lung-protective ventilation, neuroprotective strategies) before failure occurs.
DIC is the most feared hematological complication of sepsis — a paradox where the blood simultaneously clots and bleeds. Microthrombi form throughout the vasculature, consuming platelets and clotting factors, while the depletion of these factors causes uncontrolled hemorrhage. Sentinel Sepsis continuously monitors the DIC cascade: platelet count trajectory, PT/INR trend, fibrinogen levels, D-dimer, fibrin degradation products, and schistocyte counts. The system calculates real-time ISTH DIC scores, predicts progression from non-overt to overt DIC, and guides hematology-driven management including platelet and cryoprecipitate transfusion thresholds, heparin considerations, and antithrombin replacement.
Most clinicians focus on the cytokine storm — the initial hyperinflammatory phase of sepsis. But it is the second phase — immunoparalysis — that kills the majority of late sepsis deaths. After the immune system exhausts itself fighting the initial infection, it crashes into a state of profound suppression. Monocyte HLA-DR expression plummets. Lymphocyte counts collapse. The patient becomes unable to fight secondary infections — often hospital-acquired organisms like Candida, Pseudomonas, or Acinetobacter that would be manageable in an immunocompetent host. Sentinel Sepsis monitors for this transition using lymphocyte trajectories, monocyte function markers, serial procalcitonin patterns, and secondary infection surveillance — alerting infectious disease teams when immunoparalysis develops and the patient needs a fundamentally different management strategy.
The Surviving Sepsis Campaign's Hour-1 bundle requires: lactate measurement, blood cultures before antibiotics, broad-spectrum antibiotics, 30 mL/kg crystalloid for hypotension, and vasopressors for refractory hypotension — all within the first hour. Compliance with this bundle reduces mortality by 25%. Yet average compliance across US hospitals is approximately 50%. Sentinel Sepsis monitors every element of the bundle in real time, identifies compliance gaps as they occur, and alerts the care team to act — transforming a paper checklist into an automated, intelligent enforcement system.
Surviving sepsis is not the end of the story. Up to 40% of sepsis survivors are rehospitalized within 90 days. Many experience post-sepsis syndrome — persistent cognitive impairment, functional disability, chronic pain, anxiety, depression, and profound fatigue — that can last months to years. Sentinel Sepsis continues monitoring survivors after discharge through post-discharge symptom questionnaires, medication adherence tracking, primary care coordination, and early readmission risk scoring — ensuring that the investment in acute survival translates into sustained recovery.
Results from our deployed health systems.
Deployed across 9 hospitals and 2 emergency departments, Sentinel Sepsis detected 82% of sepsis cases before clinical recognition. Alert adoption rates reached 89%. In-hospital sepsis mortality dropped 39.5%. Average length of stay for sepsis patients decreased 32.3%. Thirty-day readmission rates fell 22.7%. In the first year, the system identified 4,220 actionable sepsis cases where clinician response within 3 hours of the alert produced an 18.7% relative mortality reduction compared to delayed response.
The hematology division deployed the DIC Intelligence engine across all ICU patients with sepsis. The system detected the transition from non-overt to overt DIC an average of 8 hours before standard laboratory-based recognition, enabling earlier initiation of targeted management — platelet and cryoprecipitate transfusion, antithrombin replacement, and careful anticoagulation. DIC-associated hemorrhagic complications dropped 32%. Hematology consultation was triggered automatically at the first sign of coagulopathic decompensation rather than hours later when the bleeding was already uncontrolled.
Four emergency departments deployed Sentinel Sepsis to enforce Hour-1 bundle compliance in real time. Average time to complete all bundle elements dropped from 3.2 hours to 32 minutes. Bundle compliance rose from 48% to 94%. The most impactful element: time to first antibiotic decreased from 128 minutes to 38 minutes — a change that, given the 7.6% mortality increase per hour of delay, translated directly into lives saved. Emergency physicians reported that the system's phenotype classification changed their resuscitation approach in 34% of cases.
I have been an infectious disease specialist for nineteen years. Sentinel Sepsis fundamentally changed how I practice. The phenotyping alone — knowing within the first hour whether I'm dealing with an alpha or a delta — changes everything about how I approach antimicrobials, resuscitation, and when I call hematology. This is not a screening tool. This is the operating system for sepsis management.
The DIC engine is what I've been waiting my entire career for. By the time I used to get the hematology consult, the patient was already hemorrhaging. Now the system alerts me when the coagulopathy is still in its non-overt phase — when I can actually intervene rather than react. That's not a marginal improvement. That's a paradigm shift in how we manage sepsis-associated coagulopathy.
We reduced our time to first antibiotic from over two hours to thirty-eight minutes. When you understand that every hour of delay increases mortality by 7.6%, that single metric means we're saving lives every single shift. Every single one. The system paid for itself in the first month.
Schedule a clinical demonstration of Sentinel Sepsis — configured for your patient population, your ICU acuity, and your infectious disease protocols.